Metrix COVID-19 Test
COVID-19
ApprovedActive
Key Facts
About Aptitude Medical Systems
Aptitude Medical Systems is a private, commercial-stage diagnostics company developing the Metrix platform, a next-generation, handheld molecular diagnostic system. Its lead product is the FDA-authorized Metrix COVID-19 Test for at-home and over-the-counter use, representing a significant regulatory milestone as the first such authorized molecular test using saliva or swab without a prescription. The company is leveraging this platform to build a pipeline targeting respiratory, sexual health, and other conditions, aiming to capture value in the decentralized testing market by improving access and economics for healthcare providers and consumers.
View full company profileTherapeutic Areas
Other COVID-19 Drugs
| Drug | Company | Phase |
|---|---|---|
| COVID-19 Severity Prediction Test | Age Labs | Development |
| PanCytoVir™ (oral probenecid) | TrippBio | Phase 2 |
| ARCoV | Abogen | Approved (EUA) |
| OT-101 | Sapu BioScience | Clinical Trial (Phase not specified) |
| COVID-19 Vaccine (Inactivated) | Kangtai Biological Products | Approved |
| COVID-19 Vaccine (Adenovirus Vector) | Kangtai Biological Products | Approved |
| Idylla SARS-CoV-2 Test | Biocartis | Approved |
| Adjuvanted Cell-Based COVID-19 Vaccine | CSL Seqirus | Marketed |
| Sequential Dialysis Technique | Halberd | Discovery |
| Amubarvimab + Romlusevimab (BRII-196/BRII-198) | Brii Biosciences | Approved |
| COVID-19 Vaccine Testing (for AstraZeneca) | Advaxia Biologics | Approved |
| COVID-19 Vaccine Clinical Batches | Advaxia Biologics | Clinical |